Towa Pharmaceutical Co Ltd (4553)

Currency in JPY
3,705.0
-245.0(-6.20%)
Closed·
4553 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,705.03,880.0
52 wk Range
2,764.04,490.0
Key Statistics
Bid/Ask
3,705.00 / 3,725.00
Prev. Close
3,950
Open
3,880
Day's Range
3,705-3,880
52 wk Range
2,764-4,490
Volume
209.1K
Average Volume (3m)
153.42K
1-Year Change
25.7637%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4553 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5,216.7
Upside
+40.80%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Towa Pharmaceutical Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5,216.7
(+40.80% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Nomura/Instinet
Hold4,200.00+13.36%4,500.00MaintainAug 10, 2026
Morgan Stanley
Buy5,600.00+51.15%4,500.00UpgradeJun 12, 2026
Citi
Buy4,600.00+24.16%4,900.00MaintainMay 28, 2026
Nomura/Instinet
Hold4,400.00+18.76%3,900.00MaintainMay 19, 2026
Nomura/Instinet
Hold3,900.00+5.26%3,100.00MaintainFeb 18, 2026

Earnings

Latest Release
Aug 06, 2026
EPS / Forecast
112.36 / --
Revenue / Forecast
71.38B / 71.71B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 167.95%
Dividend Yield
2.16%
Industry Median 2.51%
Annualized payout
80.00
Paid unevenly
5-Years Growth
+12.70%
Growth Streak

4553 Income Statement

Compare 4553 to Peers and Sector

Metrics to compare
4553
Peers
Sector
Relationship
P/E Ratio
22.1x12.3x−0.4x
PEG Ratio
−0.460.190.00
Price/Book
1.0x0.8x2.6x
Price / LTM Sales
0.7x1.0x3.1x
Upside (Analyst Target)
47.1%17.8%48.2%
Fair Value Upside
Unlock12.1%5.8%Unlock

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs. In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.

Employees
4923
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
8.79M17.86%32.58B
Other Institutional Investors
25.73M52.28%95.35B
Public Companies & Retail Investors
14.70M29.86%54.46B
Total
49.23M100.00%182.39B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Yoshida Jimusho K.K.40.83%20,100,00074,470,500
Sumitomo Mitsui DS Asset Management Company, Limited6.52%3,208,70011,888,234

People Also Watch

2,815.0
3110
-0.35%
10,790.0
6508
-0.55%
3,952.0
5801
+2.49%
5,580.0
5803
+7.62%
3,420.0
4061
-4.34%

FAQ

What Is the Towa Pharmaceutical (4553) Stock Price Today?

The Towa Pharmaceutical stock price today is 3,705.0 JPY.

What Stock Exchange Does Towa Pharmaceutical Trade On?

Towa Pharmaceutical is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Towa Pharmaceutical?

The stock symbol for Towa Pharmaceutical is "4553."

Does Towa Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Towa Pharmaceutical dividend yield is 2.16%.

What Is the Towa Pharmaceutical Market Cap?

As of today, Towa Pharmaceutical market cap is 182.39B JPY.

What Is Towa Pharmaceutical's Earnings Per Share (TTM)?

The Towa Pharmaceutical EPS (TTM) is 168.0.

When Is the Next Towa Pharmaceutical Earnings Date?

Towa Pharmaceutical will release its next earnings report on Nov 16, 2026.

From a Technical Analysis Perspective, Is 4553 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Towa Pharmaceutical Stock Split?

Towa Pharmaceutical has split 3 times.

How Many Employees Does Towa Pharmaceutical Have?

Towa Pharmaceutical has 4923 employees.

What is the current trading status of Towa Pharmaceutical (4553)?

As of Aug 11, 2026, Towa Pharmaceutical (4553) is trading at a price of 3,705.0 JPY, with a previous close of 3,950.0 JPY. The stock has fluctuated within a day range of 3,705.0 JPY to 3,880.0 JPY, while its 52-week range spans from 2,764.0 JPY to 4,490.0 JPY.

What Is Towa Pharmaceutical (4553) Price Target According to Analysts?

The average 12-month price target for Towa Pharmaceutical is 5,216.7 JPY, with a high estimate of 5900 JPY and a low estimate of 4200 JPY. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +40.80% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.